Skip to main content

Advertisement

SpringerLink
Log in

Alterations in levels of intermediate-chained acylcarnitines associate with weight-gain following reestablishment of euthyroidism in Graves’ disease

  • Research Letter
  • Published:
Endocrine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. G. Dimitriadis, P. Mitrou, V. Lambadiari, E. Boutati, E. Maratou, E. Koukkou, D. Panagiotakos, N. Tountas, T. Economopoulos, S.A. Raptis, Insulin-stimulated rates of glucose uptake in muscle in hyperthyroidism: the importance of blood flow. J. Clin. Endocrinol. Metab. 93(6), 2413–2415 (2008)

    Article  CAS  PubMed  Google Scholar 

  2. R.L. Mynatt, E.A. Park, F.E. Thorngate, H.K. Das, G.A. Cook, Changes in carnitine palmitoyltransferase-I mRNA abundance produced by hyperthyroidism and hypothyroidism parallel changes in activity. Biochem. Biophys. Res. Commun. 201(2), 932–937 (1994)

    Article  CAS  PubMed  Google Scholar 

  3. M.S. Jansen, G.A. Cook, S. Song, E.A. Park, Thyroid hormone regulates carnitine palmitoyltransferase Ialpha gene expression through elements in the promoter and first intron. J. Biol. Chem. 275(45), 34989–34997 (2000)

    Article  CAS  PubMed  Google Scholar 

  4. R.R. Ramsay, A. Arduini, The carnitine acyltransferases and their role in modulating Acyl-Coa pools. Arch. Biochem. Biophys. 302(2), 307–314 (1993)

    Article  CAS  PubMed  Google Scholar 

  5. C.L. Chng, A.Y. Lim, H.C. Tan, J.P. Kovalik, K.W. Tham, Y.M. Bee, W. Lim, S. Acharyya, O.F. Lai, M.F. Chong, P.M. Yen, Physiological and metabolic changes during the transition from hyperthyroidism to euthyroidism in Graves’ disease. Thyroid 26(10), 1422–1430 (2016)

    Article  CAS  PubMed  Google Scholar 

  6. M. Al-Majdoub, M. Lantz, P. Spegel, Treatment of Swedish patients with Graves’ hyperthyroidism is associated with changes in acylcarnitine levels. Thyroid 27(9), 1109–1117 (2017)

    Article  CAS  PubMed  Google Scholar 

  7. C.M. Girgis, B.L. Champion, J.R. Wall, Current concepts in graves’ disease. Ther. Adv. Endocrinol. Metab. 2(3), 135–144 (2011)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. S. Jansson, G. Berg, G. Lindstedt, A. Michanek, E. Nyström, Overweight - a common problme among women treated for hyperthydoidism. Postgrad. Med. J. 69, 107–111 (1993)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. J. Dale, J. Daykin, R. Holder, M.C. Sheppard, J.A. Franklyn, Weight gain following treatment of hyperthyroidism. Clin. Endocrinol. 55(2), 233–239 (2001)

    Article  CAS  Google Scholar 

  10. M. Ng, T. Fleming, M. Robinson, B. Thomson, N. Graetz, C. Margono, E.C. Mullany, S. Biryukov, C. Abbafati, S.F. Abera, J.P. Abraham, N.M. Abu-Rmeileh, T. Achoki, F.S. AlBuhairan, Z.A. Alemu, R. Alfonso, M.K. Ali, R. Ali, N.A. Guzman, W. Ammar, P. Anwari, A. Banerjee, S. Barquera, S. Basu, D.A. Bennett, Z. Bhutta, J. Blore, N. Cabral, I.C. Nonato, J.C. Chang, R. Chowdhury, K.J. Courville, M.H. Criqui, D.K. Cundiff, K.C. Dabhadkar, L. Dandona, A. Davis, A. Dayama, S.D. Dharmaratne, E.L. Ding, A.M. Durrani, A. Esteghamati, F. Farzadfar, D.F. Fay, V.L. Feigin, A. Flaxman, M.H. Forouzanfar, A. Goto, M.A. Green, R. Gupta, N. Hafezi-Nejad, G.J. Hankey, H.C. Harewood, R. Havmoeller, S. Hay, L. Hernandez, A. Husseini, B.T. Idrisov, N. Ikeda, F. Islami, E. Jahangir, S.K. Jassal, S.H. Jee, M. Jeffreys, J.B. Jonas, E.K. Kabagambe, S.E. Khalifa, A.P. Kengne, Y.S. Khader, Y.H. Khang, D. Kim, R.W. Kimokoti, J.M. Kinge, Y. Kokubo, S. Kosen, G. Kwan, T. Lai, M. Leinsalu, Y. Li, X. Liang, S. Liu, G. Logroscino, P.A. Lotufo, Y. Lu, J. Ma, N.K. Mainoo, G.A. Mensah, T.R. Merriman, A.H. Mokdad, J. Moschandreas, M. Naghavi, A. Naheed, D. Nand, K.M. Narayan, E.L. Nelson, M.L. Neuhouser, M.I. Nisar, T. Ohkubo, S.O. Oti, A. Pedroza, D. Prabhakaran, N. Roy, U. Sampson, H. Seo, S.G. Sepanlou, K. Shibuya, R. Shiri, I. Shiue, G.M. Singh, J.A. Singh, V. Skirbekk, N.J. Stapelberg, L. Sturua, B.L. Sykes, M. Tobias, B.X. Tran, L. Trasande, H. Toyoshima, S. van de Vijver, T.J. Vasankari, J.L. Veerman, G. Velasquez-Melendez, V.V. Vlassov, S.E. Vollset, T. Vos, C. Wang, X. Wang, E. Weiderpass, A. Werdecker, J.L. Wright, Y.C. Yang, H. Yatsuya, J. Yoon, S.J. Yoon, Y. Zhao, M. Zhou, S. Zhu, A.D. Lopez, C.J. Murray, E. Gakidou, Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384(9945), 766–781 (2014)

    Article  PubMed  PubMed Central  Google Scholar 

  11. M.G. Schooneman, A. Napolitano, S.M. Houten, G.K. Ambler, P.R. Murgatroyd, S.R. Miller, C.E. Hollak, C.Y. Tan, S. Virtue, A. Vidal-Puig, D.J. Nunez, M.R. Soeters, Assessment of plasma acylcarnitines before and after weight loss in obese subjects. Arch. Biochem. Biophys. 606, 73–80 (2016)

    Article  CAS  PubMed  Google Scholar 

  12. S.J. Mihalik, B.H. Goodpaster, D.E. Kelley, D.H. Chace, J. Vockley, F.G. Toledo, J.P. DeLany, Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity 18(9), 1695–1700 (2010)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Thanks to associate professor Bengt Hallengren for valuable discussion of the manuscript.

Funding

This work was supported by the Royal Physiographic Society, the Novo Nordisk-, Påhlsson-, the Swedish Diabetes-, Hjelt- and Crafoord Foundations, the research funds of Malmö University Hospital, the Faculty of Medicine at Lund University, the Skåne Research Foundation, the Swedish Research Council Strategic Research Area Exodiab (2009-1039) and Linnaeus grant (349-2006-237), and the Swedish Foundation for Strategic Research (IRC15-0067).

Author information

Authors and Affiliations

  1. Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden

    Mahmoud Al Majdoub, Mikael Lantz & Peter Spégel

  2. Department of Endocrinology, Skåne University Hospital, Malmö, Sweden

    Mikael Lantz

  3. Department of Chemistry, Centre for Analysis and Synthesis, Lund University, Lund, Sweden

    Peter Spégel

Authors
  1. Mahmoud Al Majdoub
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mikael Lantz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Spégel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Spégel.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Al Majdoub, M., Lantz, M. & Spégel, P. Alterations in levels of intermediate-chained acylcarnitines associate with weight-gain following reestablishment of euthyroidism in Graves’ disease. Endocrine 63, 164–166 (2019). https://doi.org/10.1007/s12020-018-1735-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-018-1735-9

Search

Navigation